Gsa Capital Partners LLP Pulse Biosciences, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$7.8 - $11.02 $257,540 - $363,858	33,018 New	33,018 $287,000
Q1 2022 May 11, 2022	SELL	$4.21 - $14.79 $46,739 - $164,198	-11,102 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.78 - $24.4 $164,087 - $270,888	11,102 New	11,102 $164,000
Q4 2018 Feb 12, 2019	SELL	$9.08 - $14.34 $108,960 - $172,080	-12,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$12.83 - $16.45 $153,960 - $197,400	12,000 New	12,000 $170,000

5.75M

94.9K

52K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $714M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.